Annual Net Income
-$17.41 M
-$25.44 M-316.91%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual net profit is -$17.41 million, with the most recent change of -$25.44 million (-316.91%) on December 31, 2023.
- During the last 3 years, APVO annual net income has risen by +$339.00 thousand (+1.91%).
- APVO annual net income is now -316.91% below its all-time high of $8.03 million, reached on December 31, 2022.
Performance
APVO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$5.10 M
+$782.00 K+13.29%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly net profit is -$5.10 million, with the most recent change of +$782.00 thousand (+13.29%) on September 30, 2024.
- Over the past year, APVO quarterly net income has increased by +$802.00 thousand (+13.59%).
- APVO quarterly net income is now -113.47% below its all-time high of $37.87 million, reached on September 30, 2017.
Performance
APVO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$23.72 M
+$1.23 M+4.94%
September 30, 2024
Summary
- As of February 8, 2025, APVO TTM net profit is -$23.72 million, with the most recent change of +$1.23 million (+4.94%) on September 30, 2024.
- Over the past year, APVO TTM net income has dropped by -$6.31 million (-36.23%).
- APVO TTM net income is now -228.24% below its all-time high of $18.50 million, reached on March 31, 2023.
Performance
APVO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
APVO Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -316.9% | +13.6% | -36.2% |
3 y3 years | +1.9% | +13.6% | -36.2% |
5 y5 years | +67.6% | +37.6% | +41.4% |
APVO Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -316.9% | +38.8% | -118.2% | +35.8% | -228.2% | +17.9% |
5 y | 5-year | -316.9% | +57.0% | -118.2% | +37.6% | -228.2% | +41.4% |
alltime | all time | -316.9% | +84.5% | -113.5% | +92.9% | -228.2% | +79.4% |
Aptevo Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.10 M(-13.3%) | -$23.72 M(-4.9%) |
Jun 2024 | - | -$5.88 M(-13.9%) | -$24.95 M(-7.6%) |
Mar 2024 | - | -$6.83 M(+15.8%) | -$27.02 M(+55.2%) |
Dec 2023 | -$17.41 M(-316.9%) | -$5.90 M(-6.8%) | -$17.41 M(+7.8%) |
Sep 2023 | - | -$6.33 M(-20.3%) | -$16.15 M(-7.5%) |
Jun 2023 | - | -$7.95 M(-386.6%) | -$17.46 M(-194.4%) |
Mar 2023 | - | $2.77 M(-159.7%) | $18.50 M(+130.4%) |
Dec 2022 | $8.03 M(-128.2%) | -$4.64 M(-39.3%) | $8.03 M(+25.5%) |
Sep 2022 | - | -$7.64 M(-127.3%) | $6.40 M(-9.2%) |
Jun 2022 | - | $28.01 M(-463.9%) | $7.04 M(-124.4%) |
Mar 2022 | - | -$7.70 M(+22.7%) | -$28.90 M(+1.5%) |
Dec 2021 | -$28.46 M(+60.3%) | -$6.27 M(-10.4%) | -$28.46 M(-2.7%) |
Sep 2021 | - | -$7.00 M(-11.8%) | -$29.24 M(+0.7%) |
Jun 2021 | - | -$7.93 M(+9.3%) | -$29.03 M(+4.0%) |
Mar 2021 | - | -$7.26 M(+2.9%) | -$27.90 M(+57.2%) |
Dec 2020 | -$17.75 M(-56.1%) | -$7.05 M(+3.9%) | -$17.75 M(-5.9%) |
Sep 2020 | - | -$6.79 M(-0.2%) | -$18.87 M(-0.7%) |
Jun 2020 | - | -$6.80 M(-334.8%) | -$19.00 M(-25.6%) |
Mar 2020 | - | $2.90 M(-135.4%) | -$25.53 M(-36.9%) |
Dec 2019 | -$40.45 M | -$8.17 M(+18.1%) | -$40.45 M(-12.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | -$6.92 M(-48.1%) | -$46.40 M(-10.8%) |
Jun 2019 | - | -$13.33 M(+10.9%) | -$52.04 M(+0.4%) |
Mar 2019 | - | -$12.02 M(-14.9%) | -$51.85 M(-3.4%) |
Dec 2018 | -$53.69 M(-870.0%) | -$14.13 M(+12.5%) | -$53.69 M(+8.9%) |
Sep 2018 | - | -$12.56 M(-4.4%) | -$49.32 M(-4547.2%) |
Jun 2018 | - | -$13.14 M(-5.1%) | $1.11 M(-63.8%) |
Mar 2018 | - | -$13.85 M(+41.9%) | $3.06 M(-56.1%) |
Dec 2017 | $6.97 M(-106.2%) | -$9.76 M(-125.8%) | $6.97 M(+290.2%) |
Sep 2017 | - | $37.87 M(-438.4%) | $1.79 M(-101.7%) |
Jun 2017 | - | -$11.19 M(+12.5%) | -$107.82 M(-1.5%) |
Mar 2017 | - | -$9.95 M(-33.5%) | -$109.47 M(-2.6%) |
Dec 2016 | -$112.42 M(+89.5%) | -$14.95 M(-79.2%) | -$112.41 M(-2.6%) |
Sep 2016 | - | -$71.74 M(+458.8%) | -$115.37 M(+104.9%) |
Jun 2016 | - | -$12.84 M(-0.4%) | -$56.30 M(-8.0%) |
Mar 2016 | - | -$12.89 M(-28.0%) | -$61.18 M(+3.1%) |
Dec 2015 | -$59.32 M(+16.0%) | -$17.90 M(+41.2%) | -$59.32 M(+43.2%) |
Sep 2015 | - | -$12.68 M(-28.4%) | -$41.42 M(+44.1%) |
Jun 2015 | - | -$17.72 M(+60.7%) | -$28.74 M(+160.7%) |
Mar 2015 | - | -$11.02 M | -$11.02 M |
Dec 2014 | -$51.12 M(-4.2%) | - | - |
Dec 2013 | -$53.34 M | - | - |
FAQ
- What is Aptevo Therapeutics annual net profit?
- What is the all time high annual net income for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual net income year-on-year change?
- What is Aptevo Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly net income year-on-year change?
- What is Aptevo Therapeutics TTM net profit?
- What is the all time high TTM net income for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM net income year-on-year change?
What is Aptevo Therapeutics annual net profit?
The current annual net income of APVO is -$17.41 M
What is the all time high annual net income for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual net profit is $8.03 M
What is Aptevo Therapeutics annual net income year-on-year change?
Over the past year, APVO annual net profit has changed by -$25.44 M (-316.91%)
What is Aptevo Therapeutics quarterly net profit?
The current quarterly net income of APVO is -$5.10 M
What is the all time high quarterly net income for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly net profit is $37.87 M
What is Aptevo Therapeutics quarterly net income year-on-year change?
Over the past year, APVO quarterly net profit has changed by +$802.00 K (+13.59%)
What is Aptevo Therapeutics TTM net profit?
The current TTM net income of APVO is -$23.72 M
What is the all time high TTM net income for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM net profit is $18.50 M
What is Aptevo Therapeutics TTM net income year-on-year change?
Over the past year, APVO TTM net profit has changed by -$6.31 M (-36.23%)